CORRECTION: A September 29, 2003 GenomeWeb News article stated that BioTrove had licensed from Genencor International a portfolio of patents and patents and patent filings related to nanofluidic through-hole array technology. In fact, BioTrove purchased the portfolio of patents from Genencor. GenomeWeb regrets the error. The corrected story is below.
NEW YORK, Sept. 29 (GenomeWeb News) - BioTrove said it has purchased from Genencor International a portfolio of patents and patent filings related to nanofluidic through-hole array technology.
BioTrove said that the intellectual property would bolster its existing through-hole array technology patent portfolio with new method and device claims. BioTrove said that the technology is used in its Living Chip platform for molecular, cell, and tissue screening and storage.
Specific terms of the licensing deal were not disclosed.